Showing results (41-50 of 159) with videos related to
Sort By:
Pageof 16
American Journal of Obstetrics and Gynecology|January 30, 2004
In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosisKenneth H H Wong, James A SimonGynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 8, 2026
Optimizing estradiol serum levels for optimal skeletal and cardiovascular health during transdermal menopausal hormone therapyPaul Charles M Piette, James A SimonMenopause (New York, N.Y.)|January 22, 2011
The evolutionary origin and significance of menopauseRicki Pollycove, Frederick Naftolin, James A SimonThe Breast Journal|June 8, 2011
Current overview of the management of urogenital atrophy in women with breast cancerSandhya Pruthi, James A Simon, Amy P EarlyCancer Journal (Sudbury, Mass.)|May 20, 2022
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer DevelopmentAbbie J Laing, Louise Newson, James A SimonDrugs|October 1, 2025
Advances in Pharmacotherapy for Menopausal Vasomotor SymptomsStephanie Young Moss, Angie Lee, James A SimonMenopause (New York, N.Y.)|October 26, 2016
Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trialJames A Simon, Tatiana Gaines, Katherine D LaGuardia, et al.Menopause (New York, N.Y.)|June 25, 2024
Sleep disturbance associated with the menopausePauline M Maki, Nick Panay, James A SimonMaturitas|February 4, 2012
Stopping menopausal hormone therapy: if breast cancer really decreased, why did colorectal cancer not increase?Gerard G Nahum, Harold Stanislaw, James A SimonThe Journal of Sexual Medicine|September 12, 2008
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal womenSheryl A Kingsberg, James A Simon, Irwin GoldsteinPageof 16